Oishi, Keiji http://orcid.org/0000-0003-4230-0450
Matsunaga, Kazuto http://orcid.org/0000-0002-0514-3241
Asami-Noyama, Maki
Yamamoto, Tasuku
Hisamoto, Yukari
Fujii, Tetsuya
Harada, Misa
Suizu, Junki
Murakawa, Keita
Chikumoto, Ayumi
Matsuda, Kazuki
Kanesada, Haruka
Kikuchi, Yujiro
Hamada, Kazuki
Uehara, Sho
Suetake, Ryo
Ohata, Syuichiro
Murata, Yoriyuki
Yamaji, Yoshikazu
Sakamoto, Kenji
Ito, Kosuke
Osoreda, Hisayuki
Edakuni, Nobutaka
Kakugawa, Tomoyuki
Hirano, Tsunahiko
Yano, Masafumi
Article History
Received: 16 June 2021
Accepted: 22 December 2021
First Online: 27 January 2022
Change Date: 25 February 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41533-022-00274-y
Competing interests
: K.O. reports the receipt of personal fees (honoraria) from Nippon Boehringer Ingelheim Co., Ltd., outside the submitted work. K.M. (Kazuto Matsunaga) reports the receipt of personal fees (honoraria) from AstraZeneca., GlaxoSmithKline K.K., Kyorin Pharmaceutical Co., Ltd., Novartis Pharma K.K., Nippon Boehringer Ingelheim Co., Ltd., and Sanofi., outside the submitted work. The remaining authors declare no competing interests.